These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 29208667)

  • 1. Etk Interaction with PFKFB4 Modulates Chemoresistance of Small-cell Lung Cancer by Regulating Autophagy.
    Wang Q; Zeng F; Sun Y; Qiu Q; Zhang J; Huang W; Huang J; Huang X; Guo L
    Clin Cancer Res; 2018 Feb; 24(4):950-962. PubMed ID: 29208667
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
    Guo L; Zhou Y; Sun Y; Zhang F
    Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression.
    Zeng F; Wang Q; Wang S; Liang S; Huang W; Guo Y; Peng J; Li M; Zhu W; Guo L
    Oncogene; 2020 Jan; 39(2):293-307. PubMed ID: 31477834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
    Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
    Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer.
    Yu J; Wang S; Zhao W; Duan J; Wang Z; Chen H; Tian Y; Wang D; Zhao J; An T; Bai H; Wu M; Wang J
    Clin Cancer Res; 2018 May; 24(9):2148-2158. PubMed ID: 29437792
    [No Abstract]   [Full Text] [Related]  

  • 6. [Establishment of A Patient-derived Xenotransplantation Animal Model for Small Cell Lung Cancer and Drug Resistance Model].
    Zhu Y; Huang W; Wu Y; Jia L; Li Y; Chen R; Guo L; Chen Q
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):6-14. PubMed ID: 30674387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-receptor tyrosine kinase Etk is involved in the apoptosis of small cell lung cancer cells.
    Guo L; Chen P; Zhou Y; Sun Y
    Exp Mol Pathol; 2010 Jun; 88(3):401-6. PubMed ID: 20206622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-495 promotes the chemoresistance of SCLC through the epithelial-mesenchymal transition via Etk/BMX.
    Wei T; Zhu W; Fang S; Zeng X; Huang J; Yang J; Zhang J; Guo L
    Am J Cancer Res; 2017; 7(3):628-646. PubMed ID: 28401017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
    Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
    Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
    Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
    Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSPAN12 promotes chemoresistance and proliferation of SCLC under the regulation of miR-495.
    Ye M; Wei T; Wang Q; Sun Y; Tang R; Guo L; Zhu W
    Biochem Biophys Res Commun; 2017 Apr; 486(2):349-356. PubMed ID: 28302484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung Cancer.
    Sen T; Tong P; Diao L; Li L; Fan Y; Hoff J; Heymach JV; Wang J; Byers LA
    Clin Cancer Res; 2017 Oct; 23(20):6239-6253. PubMed ID: 28698200
    [No Abstract]   [Full Text] [Related]  

  • 13. CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter.
    Qiu Z; Zhu W; Meng H; Tong L; Li X; Luo P; Yi L; Zhang X; Guo L; Wei T; Zhang J
    Theranostics; 2019; 9(16):4717-4729. PubMed ID: 31367252
    [No Abstract]   [Full Text] [Related]  

  • 14. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2.
    Niu Y; Ma F; Huang W; Fang S; Li M; Wei T; Guo L
    Mol Cancer; 2017 Jan; 16(1):5. PubMed ID: 28069000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-3195 inhibits non-small cell lung cancer malignant behaviors along with cisplatin resistance through targeting PFKFB4.
    Chen R; Gao X; Shen Y
    Cell Mol Biol (Noisy-le-grand); 2024 Jul; 70(7):73-78. PubMed ID: 39097893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensified Beclin-1 Mediated by Low Expression of Mir-30a-5p Promotes Chemoresistance in Human Small Cell Lung Cancer.
    Yang X; Bai F; Xu Y; Chen Y; Chen L
    Cell Physiol Biochem; 2017; 43(3):1126-1139. PubMed ID: 28977798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PFKFB4 Promotes Breast Cancer Metastasis via Induction of Hyaluronan Production in a p38-Dependent Manner.
    Gao R; Liu Y; Li D; Xun J; Zhou W; Wang P; Liu C; Li X; Shen W; Su W; Qiao H; Stupack DG; Luo N
    Cell Physiol Biochem; 2018; 50(6):2108-2123. PubMed ID: 30415245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.
    Doerr F; George J; Schmitt A; Beleggia F; Rehkämper T; Hermann S; Walter V; Weber JP; Thomas RK; Wittersheim M; Büttner R; Persigehl T; Reinhardt HC
    Sci Rep; 2017 Nov; 7(1):15511. PubMed ID: 29138515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition.
    Li D; Tong Q; Lian Y; Chen Z; Zhu Y; Huang W; Wen Y; Wang Q; Liang S; Li M; Zheng J; Liu Z; Liu H; Guo L
    Cancer Res Treat; 2021 Oct; 53(4):1042-1056. PubMed ID: 33705625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A.
    Pan B; Chen Y; Song H; Xu Y; Wang R; Chen L
    Oncotarget; 2015 Jan; 6(1):317-31. PubMed ID: 25426560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.